Theratechnologies to Present at the H.C. Wainwright 5th Annual Nash Investor Conference
MONTREAL, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Christian Marsolais, Ph.D., Senior Vice President and Chief Medical Officer, will participate at the H.C. Wainwright 5th Annual NASH Investor Conference on Tuesday, October 12, 2021 at 4:30 p.m. ET.
A live webcast of Dr. Marsolais' presentation will be available through the ?Events' section of the Company's investor relations website and will be archived for 90 days.
About Theratechnologies Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.
For investor and media inquiries: Leah Gibson Senior Director, Investor Relations [email protected] 617-356-1009
The ALS Association today celebrated the beginning of ALS Awareness Month and the 10th Anniversary of the Ice Bucket Challenge, which inspired the world to join the fight against ALS in the summer of 2014. Throughout May and the summer, the ALS...
White Glove Placement, a leading provider of staffing solutions for healthcare facilities, is proud to announce its "Scoops of Gratitude" Free Ice Cream Truck to celebrate Nurses Week and show appreciation for the dedication and hard work of nurses...
Two El Camino Health hospitals in the South Bay have earned the highest ranking for patient safety from The Leapfrog Group, a national, not-for-profit, independent evaluator that measures excellence in patient care. This national distinction marks...
Myomo, Inc. ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the...
EVP Capital Inc. ("EVP Capital"), a capital pool company ("CPC") listed on the TSX Venture Exchange Inc. (the "Exchange"), is pleased to announce that it has entered into a non-binding letter of intent dated May 1, 2024 (the "LOI") with Sharp Edge...
